查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1776863

美國的醫藥品物流市場:類型·次序·零組件·用途·業務·各地區的機會及預測 (2018-2032年)

United States Pharmaceutical Logistics Market Assessment, By Type, By Procedure, By Component, By Application, By Operation, By Region, Opportunities and Forecast, 2018-FY2032F
出版日期: | 出版商: Markets & Data | 英文 142 Pages | 商品交期: 3-5個工作天內

價格

美國醫藥物流市場規模預計將從2024年的246.9億美元成長到2032年的454億美元，複合年增長率為7.91%。

這一增長主要得益於生物製藥的興起、冷鏈監控技術的快速發展以及臨床試驗的日益分散化。該市場正成為全球最複雜、任務最關鍵的物流領域之一。醫藥物流的市場結構以高精度、合規性和嚴格的溫度控制為驅動力，它不僅運輸產品，還保障公眾健康。

本報告研究了美國醫藥物流市場，提供了市場定義和概述、市場規模趨勢和預測、細分市場的詳細分析、案例研究、影響市場成長的因素分析、競爭格局以及主要公司的概況。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 美國的關稅的影響

第4章 摘要整理

第5章 客戶的迴響

  • 法規遵守
  • 品管和可追溯性
  • 在產業的經驗和評價
  • 顧客服務與支援

第6章 美國的醫藥品物流市場展望

  • 市場規模的分析·預測
  • 市場佔有率的分析·預測
    • 類別
      • 低溫運輸物流
      • 非低溫運輸物流
    • 按次序
      • 揀貨
      • 保管
      • 搜索系統
      • 處理系統
    • 各零件
      • 保管
      • 運輸
      • 監視零組件
    • 各用途
      • 化學藥品
      • 生物醫藥品
      • 專門醫藥品
    • 按營運
      • 海路
      • 道路
      • 鐵路
      • 航空路線
      • 保管·服務
    • 各地區
      • 東北部
      • 西南部
      • 西部
      • 東南部
      • 中西部
    • 各企業市場佔有率分析(前五名公司以及其他)
  • 市場地圖分析

第7章 供需分析

第8章 價值鏈分析

第9章 波特的五力分析

第10章 大環境分析

第11章 服務價格設定模式

第12章 市場動態

  • 推動市場要素
  • 市場課題

第13章 市場趨勢·發展

第14章 政策和法規情形

第15章 案例研究

第16章 競爭情形

  • 前五名公司的競爭矩陣
  • 前五名公司的SWOT分析
  • 前十大企業的形勢
    • United Parcel Service, Inc.
    • FedEx Corporation
    • DHL Supply Chain & Global Forwarding (Deutsche Post AG)
    • Lineage Logistics Holdings, LLC
    • Americold Realty Trust, Inc.
    • Expeditors International of Washington, Inc.
    • SEKO Logistics, Inc.
    • Owens & Minor, Inc.
    • Penske Truck Leasing Co., L.P. (Penske Logistics)
    • XPO, Inc. (formerly XPO Logistics, Inc.)

第17章 策略性建議

第18章 關於調查公司·免責聲明

Product Code: MX13750

United States pharmaceutical logistics market is projected to witness a CAGR of 7.91% during the forecast period 2025-2032, growing from USD 24.69 billion in 2024 to USD 45.40 billion in 2032F, owing to biologics taking center stage, rapid innovations in cold chain monitoring, and increasingly distributed clinical trial activity. This market has quietly become one of the most complex and mission-critical logistics sectors globally. With a market built on precision, compliance, and temperature integrity, pharmaceutical logistics in the United States not only moves goods but also safeguards public health.

For instance, in April 2025, DHL Group announced a USD 2.3 billion (EUR 2 billion) strategic investment over the next five years to boost its logistics capabilities in the life sciences and healthcare sector. Supporting its "Strategy 2030," the investment will enhance DHL's infrastructure, technology, and cold chain solutions globally, with 50% allocated to the Americas and the remainder to other regions.

Cold Chain Infrastructure Expansion to Meet Biologic and Vaccine Demands Leads to Market Growth

Biopharmaceuticals and vaccine logistics have emerged as key growth areas in the United States pharmaceutical logistics, driven by heightened demand for temperature-sensitive therapies and the need for ultra-cold storage. For instance, in April 2024, Americold Realty Trust broke ground on a new 335,000-square-foot temperature-controlled facility in Missouri, in partnership with CPKC Rail. A few of the facility's features include deep-frozen zones, real-time monitoring, and rail access right outside the door. All designed to keep cross-border pharma moving, fast, safe, and at the right temperature. Every detail screams pharma-grade-nothing left to chance. These investments reflect a broader trend as cold storage is now central to logistics strategy, not just an operational add-on.

Increasing Regulatory Compliance and Certification for Pharma Handling

United States logistics firms are actively investing in globally recognized pharma certifications to win high-value contracts and ensure compliance with stringent domestic and international handling protocols. For instance, in May 2025, FedEx became the first global integrator to earn IATA CEIV Pharma corporate certification for its entire ground-handling network. This move reinforced its leadership in temperature-sensitive and compliant logistics. This milestone underscores how compliance has become a key competitive advantage. With increasing FDA scrutiny and pharmaceutical clients demanding zero-defect delivery, certified partners are becoming the default.

Specialized Pharma Driving Service Differentiation Across Logistics Chains

Specialized pharmaceuticals, from gene therapies and personalized oncology drugs to treatments for rare diseases, are reshaping the United States logistics landscape. These products demand ultra-narrow handling tolerances, GPS-enabled real-time monitoring, and delivery windows that leave no margin for error. In April 2025, United Parcel Service, Inc. expanded its specialty temperature-controlled facilities and specialized in cold chain transportation network through the acquisition of Andlauer Healthcare Group Inc. for USD 1.6 billion. This acquisition will enhance our end-to-end capabilities and services to healthcare customers requiring temperature-controlled logistics solutions in United States.

This reflects a larger trend, as therapies get more individualized, so must the logistics behind them. Custom kitting, end-to-end tracking, and validated SOPs are no longer differentiators; they are minimum requirements.

Impact of U.S. Tariffs on United States Pharmaceutical Logistics Market

Tariffs on imported APIs, medical supplies, and logistics equipment increase production and transportation expenses. Pharma companies often pass these costs to consumers, leading to rising drug prices.

Dependence on China and India for APIs forces companies to diversify suppliers or shift production to the U.S./Mexico. Temporary shortages and stockpiling occur due to trade uncertainties.

Refrigeration units, packaging materials, and tracking devices become more expensive due to tariffs. Increased demand for U.S.-based cold storage as companies hold more inventory domestically.

Switching suppliers requires FDA reapprovals, slowing down drug distribution. Companies invest in AI, blockchain, and nearshoring to optimize tariff-affected supply chains.

Key Players Landscape and Outlook

Major players dominate the United States pharmaceutical logistics market, with some being global and others homegrown. They promise cold chain warehousing, certified transport, and real-time tracking. They cater to biologics, vaccines, and clinical trials. Then you have the cold storage experts. Americold and Lineage Logistics are investing heavily, expanding, automating, and upgrading for the pharmaceutical industry. SEKO Logistics and Expeditors are tightening air-cargo links. Owens & Minor, All about medical fulfillment and hospital supplies. Personalized medicine is booming. Temperature-sensitive therapies are everywhere. Regulations are more challenging than ever. Now, it is not just about trucks and warehouses; it is about compliance, traceability, and speed.

For instance, in April 2025, Lineage, Inc. announced a significant expansion of its United States cold-storage network through a series of acquisitions, greenfield developments, and advanced automation projects. As part of this initiative, Lineage has entered a definitive agreement to acquire multiple cold storage warehouses from Tyson Foods, Inc., strengthening its longstanding partnership. Additionally, Lineage will design, build, and operate two next-generation, fully automated cold storage facilities in key United States distribution markets, with Tyson Foods serving as the anchor tenant. Lineage plans to invest approximately USD 1 billion in these acquisitions and new developments over the coming years.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Voice of Customers

  • 5.1. Regulatory Compliance
  • 5.2. Quality Management and Traceability
  • 5.3. Industry Experience and Reputation
  • 5.4. Customer Service and Support

6. United States Pharmaceutical Logistics Market Outlook, 2018-FY2032F

  • 6.1. Market Size Analysis & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share Analysis & Forecast
    • 6.2.1. By Type
      • 6.2.1.1. Cold Chain Logistics
      • 6.2.1.2. Non-Cold Chain Logistics
    • 6.2.2. By Procedure
      • 6.2.2.1. Picking
      • 6.2.2.2. Storage
      • 6.2.2.3. Retrieval Systems
      • 6.2.2.4. Handling Systems
    • 6.2.3. By Component
      • 6.2.3.1. Storage
      • 6.2.3.2. Transportation
      • 6.2.3.3. Monitoring Components
    • 6.2.4. By Application
      • 6.2.4.1. Chemical Pharma
      • 6.2.4.2. Biopharma
      • 6.2.4.3. Specialized Pharma
    • 6.2.5. By Operation
      • 6.2.5.1. Seaways
      • 6.2.5.2. Roadways
      • 6.2.5.3. Railways
      • 6.2.5.4. Airways
      • 6.2.5.5. Storage and Services
    • 6.2.6. By Region
      • 6.2.6.1. Northeast
      • 6.2.6.2. Southwest
      • 6.2.6.3. West
      • 6.2.6.4. Southeast
      • 6.2.6.5. Midwest
    • 6.2.7. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
  • 6.3. Market Map Analysis, 2024
    • 6.3.1. By Type
    • 6.3.2. By Procedure
    • 6.3.3. By Component
    • 6.3.4. By Application
    • 6.3.5. By Operation
    • 6.3.6. By Region

7. Demand Supply Analysis

8. Value Chain Analysis

9. Porter's Five Forces Analysis

10. PESTLE Analysis

11. Service Pricing Model

12. Market Dynamics

  • 12.1. Market Drivers
  • 12.2. Market Challenges

13. Market Trends and Developments

14. Policy and Regulatory Landscape

15. Case Studies

16. Competitive Landscape

  • 16.1. Competition Matrix of Top 5 Market Leaders
  • 16.2. SWOT Analysis for Top 5 Players
  • 16.3. Key Players Landscape for Top 10 Market Players
    • 16.3.1. United Parcel Service, Inc.
      • 16.3.1.1. Company Details
      • 16.3.1.2. Key Management Personnel
      • 16.3.1.3. Products and Services
      • 16.3.1.4. Financials (As Reported)
      • 16.3.1.5. Key Market Focus and Geographical Presence
      • 16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
    • 16.3.2. FedEx Corporation
    • 16.3.3. DHL Supply Chain & Global Forwarding (Deutsche Post AG)
    • 16.3.4. Lineage Logistics Holdings, LLC
    • 16.3.5. Americold Realty Trust, Inc.
    • 16.3.6. Expeditors International of Washington, Inc.
    • 16.3.7. SEKO Logistics, Inc.
    • 16.3.8. Owens & Minor, Inc.
    • 16.3.9. Penske Truck Leasing Co., L.P. (Penske Logistics)
    • 16.3.10. XPO, Inc. (formerly XPO Logistics, Inc.)

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer

List of Tables

  • Table 1. Competition Matrix of Top 5 Market Leaders
  • Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. United States Pharmaceutical Logistics Market, By Value, In USD Billion, 2018-2032F
  • Figure 2. United States Pharmaceutical Logistics Market Share (%), By Type, 2018-2032F
  • Figure 3. United States Pharmaceutical Logistics Market Share (%), By Procedure, 2018-2032F
  • Figure 4. United States Pharmaceutical Logistics Market Share (%), By Component, 2018-2032F
  • Figure 5. United States Pharmaceutical Logistics Market Share (%), By Application, 2018-2032F
  • Figure 6. United States Pharmaceutical Logistics Market Share (%), By Operation, 2018-2032F
  • Figure 7. United States Pharmaceutical Logistics Market Share (%), By Region, 2018-2032F
  • Figure 8. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 9. By Procedure Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 10. By Component Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 11. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 12. By Operation Map-Market Size (USD Billion) & Growth Rate (%), 2024
  • Figure 13. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024